OLD Category: Oncology

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma

• Nowakowski GS et al.,

Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells

• Ndreshkjana B et al.,

A stemness screen reveals C3orf54/INKA1 as a promoter of human leukemia stem cell latency

• Kaufmann KB et al.,

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling

• Watatani Y et al.,

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b–2 study

• Tilly H et al.,

miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate

• Ji Y et al.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

• Voorwerk L et al.,

Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation

• Segovia M et al.,

Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade

• Casadevall D, Li X, Powles RL...Lopez-Giraldez F, Hatzis C, Pusztai L

Host Genome Variation is Associated with Neurocognitive Outcome in Survivors of Pediatric Medulloblastoma

• Siegel BI et al.,

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

• Garcia-Diaz A et al.,

Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy

• Gubbiotti MA, Buraschi S, Kapoor A, Iozzo RV